Summary. Glycosylated haemoglobin (HbAla_c) and serum albumin (glycosyl-albumin) have been determined in patients with severe diabetic ketoacidosis and non-acidotic coma. Within one week of therapy the level of glycosyl-albumin decreased from 184 mmol 5-hydroxymethylfurfural (HMF)/mol albumin to 152 mmol HMF/mol albumin (p < 0.01) and was gradually lowered by some 40% during a period of 17 days. In contrast, the level of HbAla_ ~ remained unchanged. From these observations and findings in a patient with insulinoma, it appears that glycosyl-albumin provides a more acute measure of variation in relative glycaemia than HbAla_~, and may prove useful as a measure of medium-term diabetes control.
Patients
Studies were performed on 12 diabetic patients suffering from ketoacidosis or non-acidotic coma. Clinical data are shown in Table 1 . The patients were treated with low dose intramuscular or continuous IV infusion of insulin [7, 8] . In cases of severe ketoacidosis the amount of IV infused insulin was adapted to the changing states of insulin resistance by reducing infusion rates step by step with falling blood glucose levels as described by Rennet et al. [9] . Patients with milder ketoacidosis (pH 9 7.1) or non-acidotic coma were treated with low dose insulin administration from the very beginning. Some of the patients received in addition antibioties, digoxin, diuretics, vitamins or antihypertensive drugs. None of the patients received blood transfusions at any time. We also had the opportunity to investigate a woman suffering from insulinoma before and after surgery.
Materials
Bio-Rex 70 and Affi-Gel Blue were from Bio-Rad, Munich, FRG. Whatman DE 52 Cellulose was obtained from Hormuth & Vetter, Wiesloch, FRG. 2-Thiobarbituric acid, test-kit "System Gluc-DH UV-Test" and all other chemicals were from Merck, Darmstadt, FRG.
The glycosylated forms of haemoglobin, designated haemoglobins Ala_ c (HbAla_~), are increased in patients with imperfectly controlled diabetes mellitus [1] . Recently, serum albumin has been shown to be subject to non-enzymatic glycosylation [2] [3] [4] [5] [6] and to be elevated in the serum of diabetic patients [2] [3] [4] 6] . Little is known of the temporal relationship between the changes in the levels of blood glucose and glycosylated albumin. Patients suffering from diabetic coma offer the possibility of investigating the interdependence of fluctuations in the blood glucose and glycosyl-protein levels. The present study was designed to examine these interrelations in such patients over the course of more than 2 weeks.
Methods
Blood glucose was measured by the glucose-dehydrogenase ultraviolet method [10] . Protein was determined by the biuret method [11] . Haemoglobin was assayed by the method of van Kampen & Zijlstra [12] . For I-lbAla_ c and glycosyl-albumin analyses heparinized blood was centrifuged at 3000 • g for 10 rain immediately after withdrawal. The plasma was carefully removed and stored at -25 ~ for up to 4 weeks. The erythrocytes were washed three times with 0.9% NaC1, before haemolysis by mixing one volume of packed cells with two volumes distilled water. The haemolysate was dialyzed against developer No. 6 [13] for 18 h at room temperature and stored at --25 ~ for up to 4 weeks. HbAla_ c were determined by the macrocolumn method (column size 1 • 30 cm) by the method of Schnek and Schroeder [14] in the modification of Trivelli et al. [13] and expressed as percentage of total haemoglobin, Albumin from human plasma was purified (> 99%) by chromatography on DEAE-cellulose and 0012-186X/81/0021/0211/$01.00 Results are given as mean + SEM 5 -hydroxymethylfurfural b p < 0.01
Affi-gel blue as described previously [2, 3] . The amount of glycosyl-albumin was determined by the thiobarbituric acid assay for the 5-hydroxymethylfurfural (HMF) [15] released after 24 h hydrolysis in acetic acid 2 mold [16] at 92 ~ as described previously [31.
The interassay coefficients of variation were 6.3% (n = 33) in the HbAla_ ~ and 5.3% (n = 6) in the glycosyl-albumin determinations, Results are given as mean _+ SEM. Statistical significance in Table 2 and Figure 1 was calculated using Student's t-test for paired data. Table 1 the average initial levels of HbAla_ ~ and of glycosyl-albumin in the patients under study amounted to 16.8% and 184mmol HMF/mol albumin, respectively, i.e. an almost threefold increase compared with our normal values of 6.5% HbAla_c [17] and 64 mmol HMF/mol albumin IS]. Table 2 shows the changes in HbAla ~, glycosylalbumin and blood glucose during the first week of therapy. As can be seen, there was a non-significant reduction of nbAla__ c by 5%, whereas the level of glycosyl-albumin was significantly lowered by 17% within the same period. It appears therefore that the two glycosylated proteins respond at different rates to a lowering of the blood glucose level. This came out more clearly when the behaviour of the two glycosyl-proteins was followed for a longer period. Thus, as illustrated in Figure 1B , the level of glycosyl,albumin continued to decline markedly up to day 17 while only a small change of HbAla_~ was observed over the same interval (Fig. 1 A) . It should be noted that the control of glycaemia was comparable in both groups.
Results

As indicated in
The results obtained from a diabetic patient with highly unstable blood glucose levels are shown in Fig. 2 . No significant change in glycosyl-albumin (nor in HbAl~_c) occurred in this patient, whose blood glucose level showed marked fluctuations during the 19 days of observation.
Regarding the temporal relationship between the onset of hyperglycaemia and the augmentation of HbA~a_~ and glycosyl-albumin, we had an opportunity to study a patient suffering from an insulinoma. As illustrated in Fig. 3 a biphasic increase in blood glucose concentration occurred in this patient during and after the removal of the tumour. The first transient elevation of blood glucose (peak value = 9.3 mmol/1) lasting for about 6 h was not associated with a detectable change in the amount of glycosylalbumin. Two days later, however, after a longer phase (17 h) of hyperglycaemia, during which a maximum of 15.0 mmol/1 was reached, glycosyl-albumin was markedly elevated. In contrast, the amount of HbA1a_ ~ remained essentially constant.
Discussion
Compared with the values in our previous group of diabetics [3, 17] , uncontrolled diabetic ketoacidosis and non-acidotic hyperglycaemia were accompanied by much higher levels of glycosyl-proteins. This suggested a way of investigating whether glycosyl-albumin might be a more flexible integrative indicator of diabetic control than HbAla_ ~. We therefore compared the effect of coma therapy on the levels of both glycosyl-proteins. Our results clearly indicate that glycosyl-albumin measurements employing highly purified albumin preparations [3] reflect the amelioration of the diabetic control more rapidly than does HbAI~_ ~. Moreover they suggest that normalization of blood glucose for only short periods of time (i. e. 2 or 3 days) is not sufficient to decrease glycosylalbumin (Fig. 2) . The usefulness of HbAla_ r in monitoring long-term control of glycaemia has recently been disputed in view of several reports indicating that glycohaemoglobin levels may fall after correction of hyperglycaemia much more rapidly than expected [18] [19] [20] [21] [22] [23] [24] [25] [26] . No such rapid changes of HbAI~_ ~ could be observed in the present study. The finding of rapid changes depends on the exact technique of HbAla_r determination by column chromatography (unpublished observations). Under the conditions used in the present study, the stable rather than the labile form of glycosylated haemoglobin is assayed. Concerning the measurement of glycosylated albumin it is noteworthy that the thiobarbituric acid assay reacts only with the stable ketoamine form (Table i ). In those subjects in A also studied in B, the decrease in HbAla_ e was from 17.9 -+ 1.2 to 14.8 + 1.1%. Results are given as mean + SEM. *p < 0.01; **p < 0.025. Q ..... 9 Mean blood glucose; 9149 Haemoglobins Ala ~ (HbAla__c); A--A Glycosyl-albumin (Glyc.-Albumin). HMF = 5 -hydroxymethylfurfural of glycosyl-proteins, and not with the Schiff base [16] .
The observations on the patient with an insulinoma suggest that glycosyl-albumin is formed more rapidly than it is eliminated from the blood stream. Furthermore, they are consistent with our view that glycosyl-albumin may represent a more appropriate indicator of diabetic control than HbAla-e since it appears to be more acutely related to blood glucose levels. Day et al. [27] recently reported that alloxan-diabetic rats show an increase in gly- cosylated serum-proteins which is normalized within 2-3 days by insulin therapy. This finding, however, is not in conflict with our results, since the half-life time of rat albumin is shorter than that of human serum albumin by a factor of ten [28] .
A possible objection to the use of glycosyl-albumin as a monitoring parameter of diabetes control is that a number of substances known to be bound by albumin might influence glycosylation of albumin. In order to get some information on this point we have studied a number of the drugs in vitro taken by our diabetic patients. When tested in therapeutic concentrations, essentially no influence was exerted by insulin, digoxin, fl-methyl-digoxin, isosorbide dinitrate, frusemide, diazepam, trimethoprim, sulfamethoxazole, chloramphenicol, azlocillin, doxycyclin, or vitamins. Other sugars like mannose, galactose, fructose, and ribose were able to form glycosyl-albumin in vitro when studied over a concentration range of 6.9 to 55.5 mmol/1 (data not shown).
Taken together, our results indicate that measurement of glycosyl-albumin might prove valuable in investigating the relationship between the development of late diabetic complications and diabetic control. So far, widespread application has been hampered by the laborious technique involved, but we have now developed a simple and rapid method which should facilitate further studies [29] .
